CLOPIDOGREL 75 MG TABLET
For 30 tablets
Pharmacies pay
$1.42 filed
30 × $0.04719 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$5.30 filed
30 × $0.1766 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.7× estimated
Medicare paid 3.7× what pharmacies pay.
Part D averages every strength and form sold under “Clopidogrel” / “Clopidogrel Bisulfate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.63 estimated
$1.42 + $0.21 (15%) + $5.00 fee per fill = $6.63
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CLOPIDOGREL 75 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “clopidogrel bisulfate” and “clopidogrel”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Limited and NorthStar RxLLC.
FDA’s Established Pharmacologic Class for it is P2Y12 Platelet Inhibitor.
The NADAC file of 2026-10-14 prices it under 41 NDCs (National Drug Codes); the FDA directory lists 38 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.42 for 30 tablets (30 × $0.04719 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 14 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| NorthStar RxLLC | 6 | $0.04719 per EA filed |
| Dr.Reddy's Laboratories Inc | 5 | $0.04719 per EA filed |
| Novadoz Pharmaceuticals LLC | 4 | $0.04719 per EA filed |
| ScieGen Pharmaceuticals Inc | 4 | $0.04719 per EA filed |
| Aurobindo Pharma Limited | 3 | $0.04719 per EA filed |
| Torrent Pharmaceuticals Limited | 3 | $0.04719 per EA filed |
| Apotex Corp. | 2 | $0.04719 per EA filed |
| Ascend Laboratories, LLC | 2 | $0.04719 per EA filed |
| Macleods Pharmaceuticals Limited | 2 | $0.04719 per EA filed |
| Quallent Pharmaceuticals Health LLC | 2 | $0.04719 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 2 | $0.04719 per EA filed |
| American Health Packaging | 1 | $0.04719 per EA filed |
| Legacy Pharmaceutical Packaging, LLC | 1 | $0.04719 per EA filed |
| Westminster Pharmaceuticals, LLC | 1 | $0.04719 per EA filed |
| Not listed as a package in the FDA directory | 3 | $0.04719 per EA filed |
All 41 NDCs, with labeler and price
- 00093-7314-05 · Teva Pharmaceuticals USA, Inc. · $0.04719 per EA · eff. 2026-09-23 filed
- 00093-7314-56 · Teva Pharmaceuticals USA, Inc. · $0.04719 per EA · eff. 2026-09-23 filed
- 13668-0141-05 · Torrent Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 13668-0141-30 · Torrent Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 13668-0141-90 · Torrent Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 16714-0052-01 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
- 16714-0052-02 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
- 16714-0052-03 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
- 16714-0052-04 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
- 16714-0052-10 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
- 16714-0052-11 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
- 33342-0060-10 · Macleods Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 33342-0060-15 · Macleods Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 43598-0121-05 · Dr.Reddy's Laboratories Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 43598-0121-30 · Dr.Reddy's Laboratories Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 43598-0121-90 · Dr.Reddy's Laboratories Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 50228-0124-05 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 50228-0124-10 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 50228-0124-30 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 50228-0124-90 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
- 55111-0196-05 · Dr.Reddy's Laboratories Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 55111-0196-90 · Dr.Reddy's Laboratories Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 60505-0253-02 · Apotex Corp. · $0.04719 per EA · eff. 2026-09-23 filed
- 60505-0253-03 · Apotex Corp. · $0.04719 per EA · eff. 2026-09-23 filed
- 65862-0357-05 · Aurobindo Pharma Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 65862-0357-30 · Aurobindo Pharma Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 65862-0357-61 · not listed as a package in the FDA directory · $0.04719 per EA · eff. 2026-09-23 filed
- 65862-0357-90 · Aurobindo Pharma Limited · $0.04719 per EA · eff. 2026-09-23 filed
- 67877-0276-05 · Ascend Laboratories, LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 67877-0276-90 · Ascend Laboratories, LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 68084-0536-01 · American Health Packaging · $0.04719 per EA · eff. 2026-09-23 filed
- 68084-0536-11 · not listed as a package in the FDA directory · $0.04719 per EA · eff. 2026-09-23 filed
- 68645-0590-90 · Legacy Pharmaceutical Packaging, LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 69367-0200-05 · Westminster Pharmaceuticals, LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 72205-0199-01 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 72205-0199-05 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 72205-0199-30 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 72205-0199-90 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 82009-0021-05 · Quallent Pharmaceuticals Health LLC · $0.04719 per EA · eff. 2026-09-23 filed
- 82009-0021-90 · not listed as a package in the FDA directory · $0.04719 per EA · eff. 2026-09-23 filed
- 82009-0182-05 · Quallent Pharmaceuticals Health LLC · $0.04719 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share an FDA nonproprietary name with CLOPIDOGREL 75 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CLOPIDOGREL 75 MG TABLET this page | $0.04719 per EA filed | $0.1766 per EA filed |
| CLOPIDOGREL 300 MG TABLET | $5.29107 per EA filed | $0.1766 per EA filed |
| PLAVIX 75 MG TABLET | $8.22931 per EA filed | $7.86971 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 41 NDCs’ NADAC prices is $0.04719 per EA filed.
Of the 8 other products in FDA’s P2Y12 Platelet Inhibitor class priced per EA, 8 have a higher middle NADAC price and 0 a lower one. The one in the middle is TICAGRELOR 60 MG TABLET, at $0.28214 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $5.30 for 30 tablets, at an average of $0.1766 per EA in 2024 (2024-01-01 to 2024-12-31) for “Clopidogrel” and “Clopidogrel Bisulfate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 13,582,037 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CLOPIDOGREL 75 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Clopidogrel / Clopidogrel Bisulfate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.